Purine-Based Chromatographic Adsorbent for IgG Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current IgG-binding ligands used in affinity chromatography, such as Protein A, are protease sensitive and unstable under acidic and basic conditions, leading to leakage and contamination during purification, and existing alternatives do not offer superior binding properties or easy release methods.

Innovation Solution

A novel small organic molecule based on a purine-related structure is attached to a chromatographic resin, providing a stable and selective adsorbent for IgG purification, capable of binding all IgG subclasses without leakage issues, using a carrier like agarose with a spacer molecule like hexamethylene diamine.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If Protein A is used as an IgG-binding ligand in affinity chromatography, then IgG binding capability is achieved, but the ligand is protease sensitive and unstable under acidic and basic conditions, leading to leakage and contamination

Engineering Contradiction:
Improvestability of ligandVSAvoidleakage and contamination
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent creates a simplified copy of the IgG-binding function by using small molecule peptides (6-12 amino acids) that replicate the essential binding capability of Protein A without its structural complexity. These peptide ligands maintain IgG binding affinity while eliminating the protease sensitivity and instability issues of full-length Protein A, as they are too small to be proteolytically degraded and remain stable under harsh conditions.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The invention extracts only the essential IgG-binding functional domain from Protein A by identifying and utilizing specific short peptide sequences (such as those derived from the Z domain or other IgG-binding regions) that contain the critical binding residues. This extraction process isolates the beneficial binding function while removing the problematic structural elements that make Protein A susceptible to prote degradation and instability.

Inventive Principle:
Principle #2Taking out (Extraction)

2Adaptability or versatility

If existing small molecule ligands are used, then alternatives to Protein A are provided, but they do not offer superior binding properties or easy release methods

Engineering Contradiction:
Improvebinding propertiesVSAvoidrelease method
Core Design Contradiction:
Adaptability or versatilityVSEase of operation

Solution Approach 1:

The patent optimizes the peptide ligands by systematically varying parameters such as amino acid sequence, length (6-12 residues), and chemical modifications to enhance binding affinity and specificity for IgG. The peptide structure is tuned to achieve strong binding under physiological conditions while maintaining ease of release through standard chromatographic methods, thus improving both binding properties and operational ease simultaneously.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The purine-based adsorbent achieves generic binding of IgG subclasses with high specificity and stability, allowing for effective purification and easy release, improving the quality and efficiency of the chromatography process.

Implementation Method 1

a chromatographic adsorbent for the selective adsorption of IgG

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

use thereof for affinity chromatography

Methodology Applied
Scientific EffectAffinity chromatography:

Data Source

PatentEP1899342B1[1, 2, 4]triazolo [1, 5-a]pyrimidine derivatives as chromatographic adsorbent for the selctive adsorption of igg
Publication Date: 2013.11.27 GE HEALTHCARE BIO SCIENCES AB
  • EP1899342B1 patent drawingFigure 1
  • EP1899342B1 patent drawing
  • EP1899342B1 patent drawing

AI summary

The present invention relates to a chromatographic adsorbent for selectively adsorbing IgG, comprising the following formula (I) and its corresponding enol-form, wherein X represents O, S, or NH; R1 represents H, C1-6 alkyl, C1-6alkoxy, C1-6 alkoxy-C1-6 alkyl, Ar, -C(O)NHR3, -C(O)-R3 or halo; R2 represents H, C1-3 alkyl or halo; R3 represents H, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6alkyl or Ar; n represents 0, 1, 2 or 3; Y represents a carrier. The present invention also relates to a method of producing said adsorbent as well as use thereof for separating substances by affinity chromatography.